Summary
Semaglutide, an innovative medication, is primarily utilized to regulate blood sugar levels in adults diagnosed with type 2 diabetes. It operates as a glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking the natural hormone incretin to trigger insulin secretion.What Is Semaglutide Prescribed For?Semaglutide, available under brands like Wegovy®, Ozempic®, and Rybelsus®, is FDA-approved for various conditions. While its primary use is for treating type 2 diabetes, it's also recognized as a potential aid for weight loss in eligible individuals. Its mechanisms involve reducing hunger, slowing gastric emptying, and promoting a sense of fullness post-meals, potentially leading to reduced caloric intake.
Clinical studies have underscored its efficacy in weight management when complemented with diet and exercise. Nevertheless, its usage warrants supervision by a healthcare professional, with a careful assessment of individual benefits and risks. Moreover, adopting a comprehensive approach to weight management, encompassing diet and exercise, should be considered alongside medication for sustainable weight loss.
Semaglutide is administered via weekly injections, offering a more convenient regimen compared to diabetes medications requiring multiple daily doses.
Dosage
It is recommended to consult a licensed physician, medical director, or another qualified healthcare provider for guidance on dosage.
Concentration (per mL): Each milliliter contains 2.5 milligrams of the medication, with a total fill volume of 2.5 milliliters.
Route of Administration: This medication is intended for subcutaneous (SQ) injection use only.
